Clonidine is an imidazole derivate that acts as an agonist of alpha-2 adrenoceptors. This activity is useful for the treatment of hypertension, severe pain, and ADHD.
Clonidine was granted FDA approval on 3 September 1974.
Clonidine tablets and transdermal systems are indicated for the treatment of hypertension alone or in combination with other medications. A clonidine injection is indicated for use with opiates in the treatment of severe cancer pain where opiates alone are insufficient. An extended release tablet of clonidine is indicated for the treatment of ADHD either alo...
Washington University School of Medicine, Saint Louis, Missouri, United States
NICU @ Baystate Children's Hospital, Springfield, Massachusetts, United States
Memorial Health University Medical Center, Savannah, Georgia, United States
Clinical Pharmacology & Toxicology, University Hospital Basel, Basel, Switzerland
Cedars Sinai Medical Center, Los Angeles, California, United States
CHU de Montpellier, Montpellier, France
Dept. of Pediatrics, Oslo University Hospital Rikshospitalet, Oslo, Norway
University of Washington, Seattle, Washington, United States
Hospital e Maternidade Santa Joana, São Paulo, Brazil
CHU Clermont-Ferrand, Clermont-Ferrand, France
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.